MEN 11,420, a peptide tachykinin NK2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo

被引:25
|
作者
Lecci, A
Giuliani, S
Tramontana, M
Criscuoli, M
Maggi, CA
机构
[1] Pharmacol. Res. Dept. Menarini Ric., I-50131 Florence
关键词
urinary bladder; hyperreflexia; tachykinin antagonists NK1 receptors; tachykinin antagonists; rat;
D O I
10.1007/PL00005039
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigates the role of tachykinin NK1 and NK2 receptors in motor responses induced by the intravesical instillation of capsaicin in urethane-anaesthetized rats. SR 140,333 (1 mu mol/kg, i.v.), a non- peptide NK, receptor antagonist, abolished urinary bladder contractions induced by the selective NK1 receptor agonist [Sar(9)]SP-sulfone (0.1-100 nmol/kg, i.v.) without affecting those induced bq the NK2 receptor agonist [beta Ala(8)]NKA(4-10). MEN 11,420 (100 nmol/kg, i.v.), a cyclic peptide NK2 receptor antagonist, abolished blad- der contractions induced by [beta Ala(8)]NKA(4-10) (0.3- 300 nmol/kg, i.v.) without modifying those induced by [Sar(9)]SP-sulfone. Intravesical instillation of capsaicin (6 nmol/0.6 ml/rat) produced a motor response consisting in a primary contraction followed by a series of high amplitude phasic contractions. The intravesical instillation of saline (0.6 ml/rat) produced a primary contraction of lower amplitude with respect to that induced by capsaicin and the total area under the curve was also lower in saline-instilled rats, however the number and the amplitude of phasic contractions was similar to that induced by capsaicin. MEN 11,420 (100 nmol/kg, i.v.) did not modify motor responses induced by the intravesical administration of saline. In contrast, in capsaicin-instilled rats, MEN 11,420 (100 nmol/kg. i.v.) reduced the primary contraction, the area under the curve and also the number of phasic contractions. SR 140,333 (1 mu mol/kg, i.v.) reduced the primary contraction but not other parameters. The combination of SR 140,333 (1 mu mol/kg, i.v.) and MEN 11,420 (100 nmol/kg, i.v.) produced an additive inhibitory effect on the primary contraction but not a further inhibition on other parameters with respect to that observed with MEN 11,420 alone. In hexamethonium (110 mu mol/kg, i.v.)-pretreated animals the intravesical instillation of capsaicin produced a tonic contraction having greater amplitude and area than that induced by saline, MEN 11,420 but not SR 140,333, significantly reduced the bladder response to capsaicin in hexamethonium-pretreated rats. Again, the combined administration of MEN 11,420 and SR 140,333 did not produce further inhibitory effect in comparison to MEN 11,420 alone. It is concluded that the motor responses induced by the intravesical instillation of capsaicin are mediated by the activation of peripheral tachykinin NK2 receptors.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 27 条
  • [1] MEN 11,420, a peptide tachykinin NK2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo
    A. Lecci
    Sandro Giuliani
    Manuela Tramontana
    Marco Criscuoli
    Carlo Alberto Maggi
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 356 : 182 - 188
  • [2] Electrophysiological study on the activity of the tachykinin NK2 receptor antagonist MEN 11,420 in the guinea-pig circular colon
    Santicioli, P
    Maggi, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P191 - P191
  • [3] Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 (nepadutant) in rats
    Lippi, A
    Criscuoli, M
    Guelfi, M
    Santicioli, P
    Maggi, CA
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (11) : 1077 - 1081
  • [4] MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist
    Catalioto, RM
    Criscuoli, M
    Cucchi, P
    Giachetti, A
    Giannotti, D
    Giuliani, S
    Lecci, A
    Lippi, A
    Patacchini, R
    Quartara, L
    Renzetti, AR
    Tramontana, M
    Arcamone, F
    Maggi, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (01) : 81 - 91
  • [5] MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist
    Cialdai, Cecilia
    Tramontana, Manuela
    Patacchini, Riccardo
    Lecci, Alessandro
    Catalani, Claudio
    Catalioto, Rose-Marie
    Meini, Stefania
    Valenti, Claudio
    Altamura, Maria
    Giuliani, Sandro
    Maggi, Carlo Alberto
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 549 (1-3) : 140 - 148
  • [6] Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 in rats and guinea-pigs
    Lippi, A
    Criscuoli, M
    Santicioli, P
    Maggi, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123
  • [7] MEN 11420 is a potent antagonist at the native and transfected human tachykinin NK2 receptor
    Cucchi, P
    Patacchini, R
    Renzetti, AR
    Maggi, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125
  • [8] MEN-10,627, A NOVEL POLYCYCLIC PEPTIDE ANTAGONIST OF TACHYKININ NK2 RECEPTORS
    MAGGI, CA
    ASTOLFI, M
    GIULIANI, S
    GOSO, C
    MANZINI, S
    MEINI, S
    PATACCHINI, R
    PAVONE, V
    PEDONE, C
    QUARTARA, L
    RENZETTI, AR
    GIACHETTI, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (03): : 1489 - 1500
  • [9] Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor
    Renzetti, AR
    Catalioto, RM
    Criscuoli, M
    Cucchi, P
    Lippi, A
    Guelfi, M
    Quartara, L
    Maggi, CA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (01) : 78 - 82
  • [10] Characterization of the antibronchoconstrictor activity of MEN 11420, a tachykinin NK2 receptor antagonist, in guinea-pigs
    Tramontana, M
    Patacchini, R
    Giuliani, S
    Lippi, A
    Lecci, A
    Santicioli, P
    Criscuoli, M
    Maggi, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 352 (2-3) : 279 - 288